Search

Your search keyword '"Cross Reactions immunology"' showing total 3,785 results

Search Constraints

Start Over You searched for: Descriptor "Cross Reactions immunology" Remove constraint Descriptor: "Cross Reactions immunology"
3,785 results on '"Cross Reactions immunology"'

Search Results

1. CXCL13 promotes broad immune responses induced by circular RNA vaccines.

2. In-silico evaluation of the T-cell based immune response against SARS-CoV-2 omicron variants.

3. Profile of cross-reactivity to common pollen allergens in Northwest China based on component resolved diagnosis.

4. Analysis of Archival Sera From Norovirus-Infected Individuals Demonstrates That Cross-Blocking of Emerging Viruses Is Genotype-Specific.

5. Immune reactivity directed against the carbamylated fibrinogen α chain does not cross-react with citrullinated fibrinogen immunodominant peptides in patients with rheumatoid arthritis.

6. Dynamic changes of neutralizing antibody and memory T cell responses six months post Omicron XBB reinfection.

7. Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals.

8. A public, cross-reactive glycoprotein epitope confounds Ebola virus serology.

9. Impact of Enolase in Allergic Disease.

10. Site-specific serology unveils cross-reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes.

11. Impact of cross-reactivity and herd immunity on SARS-CoV-2 pandemic severity.

12. Cross-reactivity of hantavirus antibodies after immunization with PUUV antigens.

13. IL-10-modulated dendritic cells from birch pollen- and hazelnut-allergic patients facilitate Treg-mediated allergen-specific and cross-reactive tolerance.

14. Cephalosporin Allergy: Updates on Diagnostic Testing.

15. Finite immune imprinting on neutralizing antibody responses to Omicron subvariants by repeated vaccinations.

16. Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus.

17. Heterogeneity in Allergy to Mollusks: A Clinical-Immunological Study in a Population From the North of Spain.

18. Cross-reactivity to spelt and tolerance of barley in wheat allergy dependent on augmentation factors.

19. Development, study, and comparison of models of cross-immunity to the influenza virus using statistical methods and machine learning.

20. Longevity of hybrid immunity against SARS-CoV-2 in adults vaccinated with an adenovirus-based COVID-19 vaccine.

21. Antibody Responses in SARS-CoV-2-Exposed and/or Vaccinated Individuals Target Conserved Epitopes from Multiple CoV-2 Antigens.

22. Serologic Cross-Reactivity between the Mumps Virus Vaccine Genotype A Strain and the Circulating Genotype G Strain.

23. Inter-individual and inter-regional variability of breast milk antibody reactivity to bacterial lipopolysaccharides.

24. Enhanced Omicron Variant Neutralization by a Human Antibody Tailored to Wild-Type and Delta-Variant SARS-CoV-2 RBDs.

25. Unraveling wasp sensitization in a patient with systemic mastocytosis by CAP-inhibition assay.

26. Legume Allergens Pea, Chickpea, Lentil, Lupine and Beyond.

27. Comparison of single-chain variable fragments and monoclonal antibody against dihydroartemisinin.

28. Neglected but Clinically Relevant Allergens in Korea.

29. Food-Pollen Cross-Reactivity and its Molecular Diagnosis in China.

30. COVID-19 vaccination before or during pregnancy results in high, sustained maternal neutralizing activity to SARS-CoV-2 wild-type and Delta/Omicron variants of concern, particularly following a booster dose or infection.

31. Original antigenic sin: A potential double-edged effect for vaccine improvement.

32. Effects of genetic diversity on the allergenicity of peanut (Arachis hypogaea) proteins: identification of the hypoallergenic accessions using BALB/c mice model and in silico analysis of Ara h 3 allergen cross-reactivity.

33. Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies.

34. Enhanced and cross-reactive in vitro memory B cell response against Epstein-Barr virus nuclear antigen 1 in multiple sclerosis.

35. Variant-specific antibody profiling for tracking SARS-CoV-2 variant infections in children and adolescents.

36. A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites.

38. A Broad-specificity Neutralizing Nanobody against Hepatitis E Virus Capsid Protein.

39. Development of T cell antigen-based human coronavirus vaccines against nAb-escaping SARS-CoV-2 variants.

40. Covalent penicillin-protein conjugates elicit anti-drug antibodies that are clonally and functionally restricted.

41. The porcine circovirus 3 humoral response: characterization of maternally derived antibodies and dynamic following experimental infection.

42. Cross-Sensitisation Between Sesame and Other Seeds in Children.

43. Understanding the landscape of the SARS-CoV-2-specific T cells post-omicron surge.

44. IgE-Mediated Cannabis Allergy and Cross-Reactivity Syndromes: A Roadmap for Correct Diagnosis and Management.

45. Molecular mimicry in multisystem inflammatory syndrome in children.

46. Immune imprinting in early life shapes cross-reactivity to influenza B virus haemagglutinin.

47. Pathophysiology of drug hypersensitivity.

48. Vaccine design via antigen reorientation.

49. COBRA N2 NA vaccines induce protective immune responses against influenza viral infection.

50. The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer.

Catalog

Books, media, physical & digital resources